UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000028561 |
|---|---|
| Receipt number | R000032567 |
| Scientific Title | A phase II study of Nivolumab re-challenge therapy in patients with advanced non-small cell lung cancer who responded to prior PD-1/L1 inhibitors (WJOG9616L) |
| Date of disclosure of the study information | 2017/08/08 |
| Last modified on | 2023/05/17 11:00:00 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2017/08/07 12:46:16 | ||
| 2 | Update | 2017/09/05 09:00:21 | Organization Organization Organization Category of Funding Organization Nationality of Funding Organization Nationality of Funding Organization |
|
| 3 | Update | 2017/10/13 15:35:12 | Organization Organization Organization Category of Funding Organization |
|
| 4 | Update | 2017/10/17 17:45:45 | Recruitment status Anticipated trial start date |
|
| 5 | Update | 2018/02/13 10:17:19 | Key inclusion criteria |
|
| 6 | Update | 2019/01/25 09:54:12 | Primary outcomes Primary outcomes Key secondary outcomes Key secondary outcomes |
|
| 7 | Update | 2019/01/25 09:57:25 | Interventions/Control_1 Interventions/Control_1 Key inclusion criteria Key exclusion criteria |
|
| 8 | Update | 2019/01/25 10:06:47 | Last name of lead principal investigator Last name of lead principal investigator Organization Organization1 Tel1 Secondary IDs Study ID_1 Org. issuing International ID_1 Org. issuing International ID_1 |
|
| 9 | Update | 2019/08/09 09:33:31 | Date of IRB Last follow-up date |
|
| 10 | Update | 2019/08/09 09:37:22 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Address Organization Organization Address Address Tel |
|
| 11 | Update | 2020/04/01 09:07:33 | Recruitment status |
|
| 12 | Update | 2021/10/08 17:12:57 | Recruitment status |
|
| 13 | Update | 2023/01/11 13:59:37 | Recruitment status |
|
| 14 | Update | 2023/05/17 10:56:08 | URL releasing protocol Publication of results URL related to results and publications Number of participants that the trial has enrolled Results Results Results date posted Date of the first journal publication of results Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
|
| 15 | Update | 2023/05/17 11:00:00 | URL related to results and publications |
